Regulators

Plastic in the coronary bloodstream: micro- and nanoplastics raise a new cardiovascular warning

Singapore wants healthcare AI that does not think like the West. Cardiometabolic care is its first real test

Tissue-Agnostic Medicine Has a New Proof Point

Lung Cancer May Be Entering the Chemo-Replacement Fight

AI can flag hidden cardiac risk. The dangerous part is what health systems do next

Metabolic syndrome may leave a signature in mitochondrial DNA. The biomarker race should not outrun the evidence

Breast Cancer Gets a New PI3K Pathway Option.

Cataplexy Is Waiting on an FDA Clock

AstraZeneca’s heart drug failure raises a brutal question: how much treatment is too much treatment?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
